#Biopreservation Market

[insightfulblogz]

Biopreservation Market Type, Dynamics, and Industry Analysis by 2032

Biopreservation is an innovative method used to enhance the shelf life and safety of food products and pharmaceuticals through the use of natural or controlled microbiota and their by-products. This approach leverages the inherent properties of microorganisms, such as lactic acid bacteria, yeasts, and molds, to inhibit the growth of spoilage and pathogenic organisms, thereby maintaining product quality and safety. As global demand for safe, high-quality food products and pharmaceuticals continues to rise, biopreservation offers a sustainable alternative to synthetic preservatives, aligning with the increasing consumer preference for clean-label products that emphasize natural ingredients.

In the biotechnology sector, biopreservation plays a crucial role in the storage and transportation of biological materials, such as cell lines, tissues, and organ transplants. By employing biopreservation techniques, such as cryopreservation and controlled freezing, researchers and medical professionals can extend the viability of these materials, ensuring their effectiveness for therapeutic applications. With advancements in technology and growing awareness of the benefits of biopreservation, the field is poised for significant growth as it meets the evolving demands of the food and pharmaceutical industries.

The Biopreservation Market size was estimated at USD 2.82 billion in 2023 and is expected to reach USD 9.6 billion by 2032 at a CAGR of 28.4% during the forecast period of 2024-2032.

Future Growth

The biopreservation market is set to experience robust growth in the coming years, driven by increasing consumer awareness regarding food safety and quality, as well as the rising demand for biopreserved pharmaceuticals. As health-conscious consumers seek products free from artificial additives, manufacturers are turning to biopreservation techniques to extend shelf life while adhering to clean-label standards. Additionally, the increasing trend towards functional foods and nutraceuticals, which often require effective preservation methods to maintain bioactivity, further enhances the prospects for biopreservation.

Furthermore, the growing emphasis on sustainability within the food industry is propelling interest in biopreservation methods. By reducing food waste and extending the shelf life of products without compromising quality, biopreservation aligns with environmental goals and consumer preferences. The pharmaceutical sector is also witnessing a shift towards biopreservation as biobanks and tissue banks expand to store biological samples for research and therapeutic applications. As regulatory agencies continue to support biopreservation techniques and technologies, the market is anticipated to expand significantly over the next decade.

Drivers

Several factors are driving the growth of the biopreservation market. One of the primary drivers is the increasing incidence of foodborne illnesses and contamination, which has heightened consumer awareness and regulatory scrutiny regarding food safety. Biopreservation methods, utilizing natural microorganisms, provide an effective means of mitigating these risks and ensuring the safety of food products. As consumers prioritize health and safety, manufacturers are increasingly adopting biopreservation techniques to enhance their product offerings and build consumer trust.

Another significant factor is the expanding pharmaceutical sector, which relies heavily on biopreservation techniques for the storage and transport of biological materials. With the rise of personalized medicine and advanced therapies, the demand for biopreserved cells, tissues, and organs is escalating. Biopreservation not only ensures the longevity of these materials but also maintains their functional integrity, making it an essential component of modern biopharmaceutical research and development. Moreover, the growing trend towards sustainable practices in both food and pharmaceuticals has further fueled interest in biopreservation, as these methods align with environmental and health-conscious initiatives.

Key Takeaways

Biopreservation enhances the safety and shelf life of food products and pharmaceuticals using natural microorganisms.

The market is driven by increasing consumer awareness of food safety, demand for clean-label products, and the need for effective preservation methods in pharmaceuticals.

Key players like DuPont and BASF SE are leading the development of innovative biopreservation solutions that cater to industry needs.

The rising prevalence of foodborne illnesses and the expansion of the pharmaceutical sector are significant drivers for the biopreservation market.

Sustainable practices and the demand for functional foods and nutraceuticals are further propelling the adoption of biopreservation techniques.

Get a Free Sample Copy of the Report: https://www.snsinsider.com/sample-request/3792 

Conclusion

As the global focus on health, safety, and sustainability continues to grow, the biopreservation market is positioned for substantial growth. With its ability to enhance product quality and extend shelf life without relying on artificial additives, biopreservation represents a viable solution for both the food and pharmaceutical industries. The advancements in biopreservation technologies, coupled with increasing regulatory support, are driving innovation and expanding applications across various sectors.

In a world that prioritizes safety, quality, and sustainability, biopreservation emerges as a vital strategy to address modern challenges in food safety and biotechnology. By harnessing the power of natural microorganisms and innovative preservation techniques, biopreservation not only improves the viability of products but also aligns with consumer preferences for clean, safe, and effective solutions. As the market evolves, stakeholders must continue to invest in research and development to unlock the full potential of biopreservation and drive the future of safe, high-quality food and pharmaceutical products.

[organicmarketresearch1]

Global Biopreservation Market Size, Share, Trends, Growth & Industry 2032

Global Biopreservation market size was USD 3.11 billion in 2023 and the market is projected to touch USD 23.73 billion by 2032, at a CAGR of 25.33 % during the forecast period. Biopreservation refers to keeping alive of biological samples, cells, tissues and organs in a state of stability through cooling or freezing them so as to prolong their shelf life and retain their quality for use in future. It is very important to different sectors such as healthcare, pharmaceuticals and R&D where there is need for such materials to be kept for conducting tests or treatments or even transplanting an organ. Biopreservation market is made up of various types of products and services aimed at making this process easier including specialized storage devices, chemicals used for preventing spoilage known as cryoprotectants together with solutions which keep them alive known as preservation media among others which fall under sample management aspects or transport in different ways or even departments in specific institutions.

Recent years have witnessed a substantial increase in the global biopreservation market owing to a number of different factors. Demand for specific drugs and treatments coupled with regenerative surgeries that necessitate personal data storage on life supporting materials is one primary force creating an impact on this trend. Moreover, there is growing rates of chronic illnesses development along with rising counts of organ transplant procedures which has led to the demand for efficient biopreservation methods. However, obstacles like regulations, ethics, and expensive storage facilities seem to be preventing the market from growing. The global biopreservation market is projected to grow in the future as research into improving biopreservation techniques continues and their application area broadens, this will provide an opportunity for those concerned in healthcare industries.

Global Biopreservation report scope and segmentation.

Report Attribute

Details

Base Year

2023

Forecast Years

2024–2032

Estimated Market Value (2023)

USD 3.11 Billion

Projected Market Value (2032)

USD 23.73 Billion

Segments Covered

By Product, By Application Area, By End User, & By Region.

Forecast Units

Value (USD Million or Billion)

Quantitative Units

Revenue in USD million/billion and CAGR from 2024 to 2032.

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, GCC Countries, and South Africa, among others.

Download Free Sample Report

Global Biopreservation dynamics

There are several key factors driving the biopreservation market, one of which is increase in the demand for personalized medicine and regenerative therapies. This results in the necessity to preserve individualized biologic samples. This means that as more precise treatments are being designed for specific patients, there is an urgent need for proven biopreservation techniques to keep these samples. Furthermore, numerous other factors account for the expanding market for biopreservation solutions which is promoted by the increasing number of patients with chronic conditions as well as growing organ transplantations globally. Many people are now in need of long-term treatment such as regular medical care, then this implies a rise in the use of conserved living things for scientific study, detection, and treatment.

Similarly, biotechnology and cell therapy research can change the biopreservation market. Furthermore, given that stem cell therapy and gene editing present new opportunities, protecting biological samples is given much attention to aid in continuous research and development efforts. The world is driven by the need for new biopreservation technologies and services designed to preserve various biological materials alive and functioning. Moreover, these collaborations among academia, industry and government have played a significant role in enhancing knowledge sharing, resource availability, funds provision among others in order to support research on biopreservation.

Get Complete Report: https://organicmarketresearch.com/global-biopreservation-market

Global Biopreservation drivers

Rise in Personalized Medicine

Biopreservation market gains a lot due to the strong spike in favour of personalized medicine a medical trend that involves tailoring treatments to the individual patient’s genetic composition. This form of medicine calls for storing bodily fluids taken from a patient for future use during diagnosis or research. The rise in awareness about genetic factors determining disease susceptibility and response to treatments leads to a growing need for biopreservation solutions to hold these examples. This phenomenon does not only encourage the utilization of biopreservation techniques in health care, but also brings together biobanks with research organizations and pharmaceutical firms in order to create targeted treatments.

Advancements in Biotechnology

The demand for innovative biopreservation solutions is driven by continuous advancements in biotechnology especially in cell therapy, regenerative medicine, and tissue engineering areas. Maintaining the viability and functionality of live cells and tissues used for new therapeutic modalities being explored in the research community requires specific approaches in their preservation. Induced pluripotent stem cells (iPSCs) have revolutionized research into effective therapies. They need precise cryopreservation procedures, however, for the cell to remain intact when stored or defrosted. In view of the above, biopreservation industry stakeholders should anticipate an upward trajectory as biology burgeons and advanced therapeutics demand top of the range conservation methods.

Restraints:

Regulatory Constraints

Regulatory compliance is indeed a challenge that the market of biopreservation is facing more so regarding the storage and transportation of biological samples. As a result of these regulations and guidelines put in place, preserved specimens have to be handled, labelled and documented in accordance with stringent measures which in turn make operations in biopreservation expensive and complex. Observing international standards such as Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) is key but can pose a challenge to smaller players or players operating in multiple jurisdictions.

High Cost of Specialized Equipment

The expensive characteristic of specified biopreservation equipment like ultra-low temperature freezers, automated storage systems and cryopreservation tanks have been an enormous obstacle to market expansion. It requires a lot of funds to establish and keep running biobanks or biorepositories that have latest facilities for preservation purposes. Additionally, the present operational costs like energy consumption and maintenance increases the cost hence limiting access to advanced solutions for biopreservation especially in low-resource contexts.

Opportunities:

Expansion of Biobanking Initiatives

The increasing focus on personalized medicine and biomolecular exploration will provide opportunities for expanding global biobanking endeavours. Biobanks are essential in scientific studies, particularly in sample preservation which boosts the need for bio-preservation solutions. By creating complete biobanking networks, it will allow biopreservation providers to offer their services and technologies which have been facilitated by collaborative efforts among academic institutions, healthcare organizations and government agencies.

Segment Overview

By product, the biopreservation market is segmented into Equipment, and Biopreservation Media. Equipment includes a range of devices used for the storage and preservation of biological samples, such as ultra-low temperature freezers, liquid nitrogen tanks, and automated storage systems. These products create environments that are carefully controlled which help maintain the condition of cells, tissues, and organs for extended periods. Also, biopreservation media refers to solutions or mixtures created specifically for safeguarding biological matter from various agents while still allowing storage or shipment. Usually within them are found anti-freezes as well as anti-oxidants together with other preservatives used in order to reduce injury imposed by such process as low temperature maintenance on living cells.

By application, the biopreservation market is segmented into drug discovery, biobanking, regenerative medicine, and other application areas. In drug discovery, biopreservation plays a crucial role in preserving cell lines, tissues, and biological samples used in screening assays, pharmacokinetic studies, and toxicity testing. Biobanking includes the collection, storage and distribution of biological specimens for research, clinical trials or diagnostic objectives, thus leading to an overwhelming demand for dependable biopreservation solutions which can preserve the integrity of samples. In regenerative medicine the conservation of stem cells, tissues and organs is a prerequisite for the production of new therapies to replace damaged tissues in patients. Biopreservation, besides, is also utilized in agriculture, veterinary medicine and environmental research where there is a demand for keeping samples for a long duration period to aid in scientific study as well as other works.

Global Biopreservation Overview by Region

With its well-established healthcare facilities, extensive research and development projects, as well as huge investments into biotechnology and pharmaceutical industries, North America is the leading market in the world. Biobanks, academic institutions and industry counterparts in collaboration have led to cutting edge innovations in biopreservation technologies and service delivery in this area. Initiatives promoting personalized medicine, regenerative therapies and biobanking networks as well as stringent regulatory standards has made Europe to follow closely in order to ensure the quality and safety of biopreserved samples which in turn fosters trust among stakeholders. The Asia Pacific region can undergo a swift expansion, arising from an upsurge of healthcare expenditure in this fast-growing industry, development of biopharmaceuticals and increased attention to preservation of living organisms in medicine. China, Japan, India, among others are putting up facilities for storing samples and studying preserved organisms in order to keep pace with rising needs of the developing countries. Furthermore, emerging economies in Latin America and the Middle East & Africa are witnessing rising investments in healthcare infrastructure and research capabilities, presenting untapped opportunities for market expansion.

Global Biopreservation market competitive landscape

The competitive landscape of the biopreservation market is identified by the presence of several key players, including Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, BioLife Solutions Inc., and Avantor Inc. These companies dominate the market through their extensive product portfolios, strong distribution networks, and strategic partnerships. They focus on innovation to develop advanced biopreservation solutions that meet the evolving needs of healthcare, pharmaceutical, and research industries. Additionally, mergers and acquisitions play a significant role in influencing the competitive factors, enabling companies to expand their market presence and enhance their capabilities in biopreservation technologies and services. In addition, the biopreservation domain is being penetrated by small companies and new market participants who offer narrow specialized products for certain uses or market segments. This increases competition and prompts larger corporations that wish to remain competitive to spend more on R&D activities.

Global Biopreservation Recent Developments

November 2023, BioLife Solutions announced a fundraising of USD 10.4 million through a private placement by Casdin Capital. The funds are intended to support ongoing operations related to biopreservation media and other offerings.

October 2022, Azenta, Inc. completed the acquisition of B Medical Systems S.á r.l and its subsidiaries. B Medical Systems is renowned for providing temperature-controlled storage and transportation solutions crucial for delivering life-saving treatments worldwide.

July 2022, the inauguration of Cellutions BioStorage took place in Chennai, India. As a research-to-launch Cryopreservation Bank, Cellutions BioStorage offers comprehensive biomaterial storage and logistics services. It caters to biopharmaceutical firms seeking to outsource supply chain management throughout a product’s life cycle. The newly opened facility spans 25,000 square feet and boasts state-of-the-art infrastructure.

Contact Us: Mob : +91 9319642100 Noida One Tower Sec 62 Noida 201301 Sales : sales@organicmarketresearch.com Website : https://www.organicmarketresearch.com

[univdatosmarket]

Biopreservation Market was valued at US$ 5 billion in 2020 and is expected to grow at a CAGR of 14% over the forecast period (2021-2027)

[tbrcresearchreport]

The Business Research Company offers biopreservation market market research report 2023 with industry size, share, segments and market growth

[insightslicelive]

Biopreservation Market Trends Analysis, Size, Key Insights and Overview by 2032 | Atlanta Biologics, Lifeline Scientific, LabVantage Solutions

Biopreservation Market Trends Analysis, Size, Key Insights and Overview by 2032 | Atlanta Biologics, Lifeline Scientific, LabVantage Solutions

The Global Biopreservation Market 2023 to 2032 report provides details of new recent developments, trade regulations, import-export intelligence, supply chain balance, share, the impact of domestic and localized market players, opportunities in terms of emerging revenue pockets, changes in market regulations, strategic growth analysis, size, category growths, application niches and dominance,…

[latestmarketresearchnews]

Biopreservation Industry Research Report 2030 by Key Growth Drivers, Leading Players Review

The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.

The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.

The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Regional Insights:

North America Biopreservation Market Trends

North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.

Key Growth Factors:

High prevalence of chronic diseases requiring biopreservation for treatment.

Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).

Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.

Asia Pacific Biopreservation Market Trends

Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.

Key Drivers:

Rising funding for bio-banking techniques.

Increasing collaborations and partnerships to develop advanced biopreservation services.

Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.

The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.

Key Companies & Market Share Insights:

The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:

Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.

Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.

In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.

Key Biopreservation Companies:

Azenta US, Inc.

Biomatrica, Inc.

BioLife Solutions

MVE Biological Solutions

LabVantage Solutions, Inc.

Taylor-Wharton.

Thermo Fisher Scientific, Inc.

Panasonic Corporation

X-Therma Inc.

Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

Biopreservation Industry 2030 Trends, Growth, Revenue, Outlook and Future Estimation

The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.

The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.

The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Regional Insights:

North America Biopreservation Market Trends

North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.

Key Growth Factors:

High prevalence of chronic diseases requiring biopreservation for treatment.

Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).

Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.

Asia Pacific Biopreservation Market Trends

Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.

Key Drivers:

Rising funding for bio-banking techniques.

Increasing collaborations and partnerships to develop advanced biopreservation services.

Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.

The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.

Key Companies & Market Share Insights:

The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:

Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.

Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.

In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.

Key Biopreservation Companies:

Azenta US, Inc.

Biomatrica, Inc.

BioLife Solutions

MVE Biological Solutions

LabVantage Solutions, Inc.

Taylor-Wharton.

Thermo Fisher Scientific, Inc.

Panasonic Corporation

X-Therma Inc.

Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[marketresearchreportinsight]

Biopreservation Industry 2030 Outlook by Growth Rate, Trends, Size and Opportunities

The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the…

[marketanalysisdata]

Biopreservation Market Revenue, Share and Growth Rate to 2030

The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.

Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.

In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.

However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.

Application Segmentation Insights:

In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.

The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[marketstudyreport]

Biopreservation Market Competitive Landscape and Industry Analysis 2030

The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.

Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.

In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.

However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.

Application Segmentation Insights:

In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.

The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[industrynewsupdates]

Biopreservation Market Key Companies, Growth and Forecast Report, 2030

The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 

Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.

Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Marke

Biopreservation Market Report Highlights

• By product, the equipment segment held the largest revenue share of over 78.75% in 2022 due to the rising demand for bio-banking to preserve stem cells, DNA, plasma, and tissue culture. Increasing demand for modified genetic material in the global market is also fueling the growth

• The bio-banking application segment held the largest revenue share in 2022. This can be attributed to rising awareness regarding stem cell preservation, increasing acceptance of sperm and egg banking, and utilization of assistant reproductive technology in animals

• North America dominated the global market in 2022 due to the advancement in biomedical research, the development of advanced therapies, and the upsurge in research activities related to DNA sequencing and bioinformatics

• Asia Pacific is expected to grow considerably in the future owing to rising investments in Asian countries and increasing partnerships and collaborations with key players

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global cancer stem cells market size was valued at USD 2.89 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030.

• The global DNA methylation market size was valued at USD 1.47 billion in 2023. It is expected to expand at a compound annual growth rate (CAGR) of 14.1% from 2024 to 2030.

Biopreservation Market Segmentation

Grand View Research has segmented the global biopreservation market on the basis of product, application, and region:

Biopreservation Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Equipment

o Freezers

o Refrigerators

o Consumables

o Vials

o Straws

o Microtiter Plates

o Bags

o Liquid Nitrogen

• Media

o Pre-formulated

o Home-brew

• Laboratory Information Management System (LIMS)

Biopreservation Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Regenerative Medicine

o Cell Therapy

o Gene Therapy

o Others

• Bio-banking

o Human Eggs

o Human Sperms

o Veterinary IVF

• Drug Discovery

Biopreservation Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o Germany

o U.K.

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o Japan

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[healthcaredbmrnews]

[newsheadlinesnow]

Biopreservation Market worth $7.1 billion by 2029 | MarketsandMarkets™

http://dlvr.it/TDkL5S

[columbianewsupdates]

Biopreservation Market worth $7.1 billion by 2029 | MarketsandMarkets™

http://dlvr.it/TDkHWQ